Deepcell

Deepcell is a biotechnology company focused on single-cell analysis, classification, and sorting.

Founded in 2017 and based in Menlo Park, California, Deepcell utilizes an integrated platform that combines artificial intelligence, high-resolution imaging, and microfluidics. The company aims to provide novel biological insights through cell morphology, allowing for label-free analysis that preserves cell viability and enables the isolation of rare cell types. Deepcell offers a range of services, including single-cell phenotyping, cell enrichment, and access to its proprietary REM-i platform. This platform features advanced imaging and AI-powered analysis for precise cell classification and sorting. The company serves various sectors, including life sciences research, translational research, diagnostic testing, and therapeutics development. With approximately $100 million in funding and a strategic partnership with NVIDIA, Deepcell is committed to advancing precision medicine and enhancing its technology for broader applications in biology and healthcare.